Clinical Trial Update: Utility of Exparel Based ESP Blocks in Elective Posterior Spine Fusion [Phase 4]

View source ↗

Summary

Phase 4 clinical trial update evaluating the utility of Exparel-based ESP blocks in elective posterior spine fusion surgery.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Spine Fusion

Drugs mentioned

• Exparel (liposomal bupivacaine)

Snippet

Sponsor: Hartford Hospital | Conditions: Spine Fusion, Anesthesia, Local | Phase 4 | Status: UNKNOWN